In the last couple of years, Professor Syed Hussain has become increasingly concerned by the growing number of patients presenting with bladder cancer at an advanced stage. “Since Covid, there has ...
The FDA recently approved a pretzel-shaped implant that helps some bladder cancer patients keep their bladder. Dr. Chris ...
It’s important to know what kinds of treatments are available for bladder cancer and understand that having a “tailored” treatment is important for patients, experts said. There are so many types of ...
Imagine a targeted approach to bladder cancer that spares healthy cells while delivering chemotherapy directly to cancerous ...
A phase 2/3 multicenter trial evaluating safety and efficacy of a new mucoadhesive gemcitabine suspension for ablation of upper tract urothelial carcinoma. ABLE-22: Safety and efficacy evaluation of ...
Squamous cell carcinoma (SCC) of the bladder is a distinct and rarer form, accounting for approximately 2% to 5% of all bladder cancers in the U.S. It develops in the flat, thin squamous cells that ...
Of the approximately 82,000 people diagnosed with bladder cancer in the U.S. each year [1], many find their quality of life completely upended. Between demanding symptoms, side effects of treatment, ...
NewsNation on MSN
How does nonchemotherapy cancer treatment Anktiva work?
The treatment harnesses the body’s immune system to destroy cancer tumors, which could make chemotherapy obsolete.
Bladder cancer is the ninth most common cancer in the world, the fourth most common cancer in men, and the 11th most common ...
CG Oncology is testing an engineered immunotherapy to treat bladder cancer A biomedical company, CG Oncology Inc., may be taking on industry giants Merck and Ferring Pharmaceuticals with a new way to ...
A breakthrough in bladder cancer treatment is helping save more lives. The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year. 17,000 will die from ...
The FDA has approved Pfizer and Astellas’ Padcev (enfortumab vedotin-ejfv) plus Merck’s Keytruda (pembrolizumab) as a perioperative treatment for adults with muscle-invasive bladder cancer who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results